Efficacy and safety of fermented oyster extract for height of children with short stature: a randomized placebo-controlled trial.

Background: Some experimental studies have established the effect of oysters on the promotion of body growth. Yet, there is a lack of human clinical studies. The objective of this study was to evaluate the effect of a fermented oyster (FO) extract on the increase in the height of children with stature in the 25th percentile by age.

Methods: In total, 100 children (6-11 years old) were randomly divided into two (FO or control) groups. For 24 weeks, the subjects in the FO group took the FO extract once daily before sleeping, whereas the control group took placebo extracts, simultaneously. We evaluated the height gain, height velocity (HV), height standard deviation score (SDS), urine deoxypyridinoline (DPD), growth hormone (GH), insulin-like growth factor (IGF-1), and IGF binding protein 3 (IGFBP-3).

Results: The height gain and height SDS were significantly higher in the FO group than in the placebo group after 24 weeks (height gain:  < 0.001, height SDS:  < 0.005). The HV was also significantly higher in the FO group than in the placebo group after the 6th and 24th week ( = 0.001,  = 0.004). After 24 weeks, we observed a decrease in GH, IGF, and IGFBP-3 in both groups. However, serum IGFBP-3 level in the FO group reduced less than placebo group.

Conclusion: FO supplementation may help to increase the height of children, and the effect might be mediated via effects on the IGFBP-3 levels.